Neuronetics is trading 10.1% up today at $2.18 as its late-July rebound extends and speculative interest stays elevated.
- The move appears driven by trader engagement and technical momentum, as there are no new company-specific headlines or filings today.
- Sentiment is further bolstered by a broader risk-on tone in U.S. equities, with major indexes all gaining more than 1%.